Core Insights - TeleVox has launched the Planned Outreach Program to enhance patient engagement for small practices, addressing the outreach gap in patient care [1][3] - The TeleVox Practice Edition platform has been recognized as the "Best Practice Management Solution" in the MedTech Breakthrough Awards, showcasing its effectiveness in improving healthcare delivery [1][5] Product Features - The Planned Outreach Program includes prebuilt, specialty-specific campaigns and templates for seasonal and recurring care needs, allowing practices to proactively plan outreach [2] - Features such as the Annual Campaign Planning and Smart List Builder facilitate targeted communication by leveraging past appointment data and patient contact lists [2] - Communication can be delivered via SMS or IVR, ensuring convenience for patients, while follow-up features help re-engage non-responsive patients [2] Market Impact - The Planned Outreach Program aims to democratize access to advanced engagement technology for small practices, enabling them to provide proactive care similar to larger health systems [3] - By improving patient follow-up care, such as vaccinations and annual checkups, the program is expected to enhance patient health outcomes and increase practice revenue [3] - The platform reduces manual tasks for staff, improving operational efficiency and allowing for a more personalized patient care experience [3] Company Background - TeleVox is part of WestCX within West Technology Group and has been recognized for its innovation in digital patient relationship management [5] - The company serves over 7,000 healthcare organizations, including hospitals and community health centers, focusing on effective patient engagement and communication [5] - TeleVox integrates its solutions with electronic health records (EHR) to support automated, personalized interactions with patients [5]

Core Points - CareCloud has surpassed the accelerated filer threshold with a public float of $85.1 million as of June 30, 2025, triggering new compliance requirements under SEC regulations [1] - The achievement is seen as a validation of CareCloud's growth trajectory and investor confidence, with a commitment to compliance and corporate governance emphasized by the Co-CEO [2] - The current audit firm cannot perform the required ICFR attestation, necessitating a change in auditors to ensure compliance [2] - CareCloud has initiated a process to engage a new audit firm capable of fulfilling the necessary services for fiscal year 2025 [3] Company Overview - CareCloud specializes in AI-driven healthcare technology solutions, helping over 40,000 providers enhance patient care while reducing administrative burdens and operating costs [4]

BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company” or “TRX”), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. (“Ucare”), the sole operator of China’s only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX’s strategy to expand into in-hospital distribution channel ...

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [5] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes through early identification and management of chronic diseases [5] Recent Developments - Clover Health announced its inclusion in the Russell 3000® Index, effective June 30, 2025, as part of the annual reconstitution of the Russell indexes [1][2] - This inclusion is expected to enhance the company's visibility within the investment community and is seen as a significant achievement in broadening awareness and engagement [3] Market Context - The Russell 3000® Index includes the 4,000 largest US stocks ranked by total market capitalization as of April 30, 2025, and membership lasts for one year [2] - Membership in the Russell 3000® Index also grants automatic inclusion in either the large-cap Russell 1000® Index or the small-cap Russell 2000® Index, along with relevant growth and value style indexes [2] Industry Impact - The Russell indexes are widely utilized by investment managers and institutional investors, with approximately $10.6 trillion in assets benchmarked against them as of June 2024 [3] - FTSE Russell, the provider of these indexes, is recognized for its objective market capitalization and style attributes in determining membership [2][3]

Key Takeaways DOCS' enterprise tools now drive growth, with AI usage up 5x and 620K+ prescribers engaged. DOCS' Multi-module campaigns and client portals boost revenue visibility and retention to 119%. Shifting to enterprise brings longer sales cycles, but DOCS is retraining teams to support the pivot.Doximity (DOCS) is gradually transforming from a physician-focused social network into a broader healthcare technology platform. This shift is increasingly anchored in enterprise offerings — workflow tools, ...

Core Viewpoint - CareCloud, Inc. may need to engage a new independent registered public accounting firm if an ICFR auditor attestation is required for fiscal year 2025 due to its current audit firm's inability to perform the required services [1][2]. Group 1: Audit and Compliance - The current audit firm has indicated it lacks the capacity to perform an ICFR attestation, which is necessary if CareCloud's public float exceeds $75 million [2]. - The determination of whether an ICFR attestation is required will be based on CareCloud's public float as of June 30, 2025, with a threshold of $75 million for classification as an accelerated filer [3]. - CareCloud plans to provide an update on July 1, 2025, regarding its public float and any implications for its audit arrangements [3]. Group 2: Company Overview - CareCloud is a leader in AI-driven healthcare technology solutions, offering services that enhance financial and operational performance, streamline clinical workflows, and improve patient experiences [4]. - The company serves over 40,000 providers, focusing on reducing administrative burdens and operating costs through its suite of solutions, including revenue cycle management, practice management, electronic health records, and digital health [4].

Core Insights - Amesite Inc. has enhanced its NurseMagic™ app to support charting in 16 languages, addressing the needs of nearly 1 million ESL nurses in the U.S. [1][2] - The company reported a 2.4x quarter-on-quarter revenue increase, driven by the rapid adoption of NurseMagic™ and improved operating efficiency [4][5] Company Developments - NurseMagic™ now supports languages including English, Chinese, Hindi, Spanish, French, Portuguese, Russian, Indonesian, German, Japanese, Korean, Turkish, Italian, Ukrainian, Dutch, and Swedish [3] - The company has launched a higher-priced enterprise tier to meet growing B2B demand for increased capacity [4] - NurseMagic™ reduces documentation time for nurses from 20 minutes to just 20 seconds, enhancing operational efficiency [5] Market Positioning - The multilingual capability of NurseMagic™ positions Amesite to capture value in both domestic and international markets, particularly among the 19.2% of U.S. nurses who speak English as a second language [2][6] - The platform serves B2B and B2C users across 50 states and 21 countries, with seamless integration into healthcare workflows [5]

Strategic collaboration expands HealthLynked's focus on interoperability and digital transformation in hospital systems and EMRsNAPLES, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a pioneer in healthcare technology and patient engagement, today announced a strategic partnership with Endlink, a healthcare data integration firm led by industry veteran Rubén Viera. This alliance underscores HealthLynked's commitment to building robust partnerships that enhance connectiv ...

Veradigm (MDRX) Update / Briefing June 24, 2025 08:00 AM ET Speaker0 Greetings, and welcome to the Veradigm Investor Update Conference Call and Webcast. At this time, all participants are in a listen only mode. As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Jenny Jelenis, Vice President, Investor Relations. Jenny, please go ahead. Speaker1 Thank you very much. Good morning, and welcome to the Veradigm update conference call. Our speakers today are Tom Langan, ...

Core Insights - OptimizeRx Corp. has appointed Steve Silvestro, the current CEO, to its Board of Directors effective June 20, 2025, enhancing leadership and execution of value creation plans [1][2][3] Company Leadership - Steve Silvestro joined OptimizeRx in 2019, became CEO in March 2025, and previously served as interim CEO from January 2025 [2][4] - The Board of Directors has recognized Silvestro's leadership and the progress made under his tenure, which has strengthened the company's position and laid a foundation for long-term shareholder value [3] Strategic Direction - Silvestro expressed optimism about OptimizeRx's direction, emphasizing a focus on operational excellence, customer satisfaction, and a strong outlook for 2025 and beyond [3] - The company aims to deepen its value proposition with pharmaceutical partners, accelerate the shift towards a recurring revenue model, and progress towards achieving Rule of 40 performance [3][4] Company Overview - OptimizeRx is a healthcare technology company that connects life science brands with patients and healthcare providers through innovative AI-driven tools [5][6] - The company is committed to privacy-safe, patient-centric technology, partnering with leading pharmaceutical and life sciences companies to transform healthcare [6]